8.59
-0.07
(-0.81%)
At close: January 31 at 5:35:52 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CASEY MARK J Officer | Conversion of Exercise of derivative security | Dec 11, 2024 | 29,187 |
| DUBOVSKY FILIP Officer | Sale | Jun 17, 2024 | 66,613 |
| JACOBS JOHN C Chief Executive Officer | Conversion of Exercise of derivative security | Jan 23, 2025 | 91,849 |
| KELLY JAMES PATRICK Chief Financial Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 32,602 |
| KING RACHEL K Director | Sale | Dec 13, 2024 | 14,770 |
| MCGLYNN MARGARET G Director | Conversion of Exercise of derivative security | Jun 12, 2024 | 10,470 |
| MOTT DAVID M Director | Conversion of Exercise of derivative security | Jun 12, 2024 | 50,470 |
| RODGERS RICHARD J. Director | Conversion of Exercise of derivative security | Oct 29, 2024 | 14,270 |
| TRIZZINO JOHN J Officer | Conversion of Exercise of derivative security | Aug 19, 2024 | 28,310 |
| YOUNG JAMES FRANCIS Director | Sale | Dec 31, 2024 | 51,760 |
Related Tickers
BIO3.DE Biotest Aktiengesellschaft
28.00
+2.19%
BIO.DE Biotest Aktiengesellschaft
41.40
0.00%
9VC.DE Atai Life Sciences N.V.
1.4955
+2.89%
T5O0.DE bioXXmed AG
0.9600
+10.85%
88Q.DE 4basebio PLC
14.00
+0.72%
PSH.DE Sernova Corp.
0.1447
+0.56%
7V0.DE Darwin AG
26.00
+0.78%
VX1.DE Vertex Pharmaceuticals Incorporated
445.25
+5.17%
AYJ.DE Valneva SE
2.7600
+11.29%
HPHA.DE Heidelberg Pharma AG
2.3900
-2.45%